Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunohistochemical assay for detecting expression of programmed death ligand 1 (PD-L1) in tumor tissue

Immunohistochemical assay for detecting expression of programmed death ligand 1 (PD-L1) in tumor tissue

US Patent 11193937 · Granted Dec 7, 2021

Estimated economic value: $356,600,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dynamic distribution of container images2025
Dynamic distribution of container images2023
Plasmid constructs for heterologous protein expression and methods of use2023
Scoring methods for anti-PD therapy eligibility and compositions for performing 2023
Method for the treatment of malignancies2023
Systems and methods for improved tissue-sensing based electroporation2022
Scoring methods for anti-PD therapy eligibility and compositions for performing 2020
Method for the treatment of malignancies2019
Immunohistochemical proximity assay for PD-1 positive cells and PD-ligand positi2019
Antibodies that bind to human programmed death ligand 1 (PD-L1)2017
Correlation of molecular markers with clinical outcome in GBM patients radiation2013
Methods for determining signal transduction activity in tumors2013